Pneumococcal conjugate vaccine given shortly after birth stimulates effective antibody concentrations and primes immunological memory for sustained infant protection.
about
Pneumococcal vaccination during pregnancy for preventing infant infectionOntogeny of early life immunityThe prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, KenyaSafety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trialSerum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort studyPredictors of Uptake and Timeliness of Newly Introduced Pneumococcal and Rotavirus Vaccines, and of Measles Vaccine in Rural Malawi: A Population Cohort Study.Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants.Pneumococcal carriage in sub-Saharan Africa--a systematic review.Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makersSystematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth.Pneumococcal Vaccine Response After Exposure to Parasites in Utero, in Infancy, or Mid-Childhood.Maternal and neonatal pneumococcal vaccination - where are we now?Neonatal invasive pneumococcal disease: New Zealand experience in the era of pneumococcal vaccination.Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era.Antibody concentrations against the infecting serotype in vaccinated and unvaccinated children with invasive pneumococcal disease in the United Kingdom, 2006-2013.Effect of maternally-derived anti-protein and anti-capsular IgG antibodies on the rate of acquisition of nasopharyngeal carriage of pneumococcus in newborns.Vaccine responses in newborns.Neonatal Immunization: Rationale, Current State, and Future Prospects.Limited impact of neonatal or early infant schedules of 7-valent pneumococcal conjugate vaccination on nasopharyngeal carriage of in Papua New Guinean children: A randomized controlled trial
P2860
Q24186525-905D68BF-2C25-4BBF-A8D4-0238475CF086Q27000632-47210417-CB77-4157-8D9D-F17F65FE64EBQ28731923-7EC50523-9AE6-428B-B4E7-787914ACCBD6Q34602513-238DF3CC-706B-4EBF-97E5-AD0987E73B12Q34803614-5D411355-0F8A-451A-8D6E-6979382218E1Q36010573-A892EA0E-8D41-4A76-89B8-C701591162EBQ36822003-A83EE624-8938-4B62-9ECE-8451637CB475Q37495709-78BCC69B-AC60-43C9-BEF2-7CC6327AD4FCQ37613613-A8037F33-D7DF-4247-A9B0-830BAE739E32Q37613616-F24A25D2-9E20-4E17-85DD-AE310F97D414Q37613922-16ADFAF0-FC17-4560-B61A-F843E963509FQ37621061-0FF1B762-DB3F-4D98-8360-655BAE2C10C1Q37713832-B2F4B8E0-E5A3-4B4E-AC40-8D51C23A6A48Q38902526-24B280F5-9D85-4613-B0E9-2CA804A39A84Q38948154-717CD295-F068-4ACB-AD66-990AB361ED77Q39484402-DCE0A2DC-C2FB-4B1D-BD91-A73BE64CD7B4Q40210431-45C59B63-89B1-411C-89B6-A7E06D4D117CQ41451800-2BBB5E8A-B6C8-4081-B10F-0DAB93BD417DQ41987151-75B6B692-BC4D-483E-AB59-6AF64F3A94A3Q46301580-8E0DA578-7A3D-4D47-9C25-950453550A8FQ52579157-FA0D30E3-E58D-4710-BF7D-C1710BA09250Q57272219-FE9F1EBC-9B59-45B6-9101-6AF5D0CDA18C
P2860
Pneumococcal conjugate vaccine given shortly after birth stimulates effective antibody concentrations and primes immunological memory for sustained infant protection.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pneumococcal conjugate vaccine ...... r sustained infant protection.
@ast
Pneumococcal conjugate vaccine ...... r sustained infant protection.
@en
type
label
Pneumococcal conjugate vaccine ...... r sustained infant protection.
@ast
Pneumococcal conjugate vaccine ...... r sustained infant protection.
@en
prefLabel
Pneumococcal conjugate vaccine ...... r sustained infant protection.
@ast
Pneumococcal conjugate vaccine ...... r sustained infant protection.
@en
P2093
P2860
P356
P1476
Pneumococcal conjugate vaccine ...... r sustained infant protection.
@en
P2093
Anne Muhoro
J Anthony G Scott
Lindsey Ashton
Polly Burbidge
P2860
P304
P356
10.1093/CID/CIR444
P407
P577
2011-08-23T00:00:00Z